共 50 条
Inferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia
被引:13
|作者:
Almamun, Md
[1
]
Kholod, Olha
[1
]
Stuckel, Alexei J.
[1
]
Levinson, Benjamin T.
[1
]
Johnson, Nathan T.
[2
]
Arthur, Gerald L.
[1
]
Davis, J. Wade
[3
]
Taylor, Kristen H.
[1
]
机构:
[1] Univ Missouri Columbia, Dept Pathol & Anat Sci, Columbia, MO USA
[2] Worcester Polytech Inst, Bioinformat & Computat Biol, Worcester, MA 01609 USA
[3] Univ Missouri Columbia, Dept Hlth Management & Informat, Columbia, MO USA
基金:
美国国家卫生研究院;
关键词:
DNA methylation;
enhancer;
acute lymphoblastic leukemia;
eRNA;
transcription factor;
precursor B-cell;
TRANSCRIPTION;
ENHANCERS;
CHROMATIN;
REVEALS;
CANCER;
5-AZACYTIDINE;
INTEGRATION;
MACROPHAGE;
ELEMENTS;
TOPHAT;
D O I:
10.1080/10428194.2016.1272683
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
A complete understanding of the mechanisms involved in the development of pre-B ALL is lacking. In this study, we integrated DNA methylation data and gene expression data to elucidate the impact of aberrant intergenic DNA methylation on gene expression in pre-B ALL. We found a subset of differentially methylated intergenic loci that were associated with altered gene expression in pre-B ALL patients. Notably, 84% of these regions were also bound by transcription factors (TF) known to play roles in differentiation and B-cell development in a lymphoblastoid cell line. Further, an overall downregulation of eRNA transcripts was observed in pre-B ALL patients and these transcripts were associated with the downregulation of putative target genes involved in B-cell migration, proliferation, and apoptosis. The identification of novel putative regulatory regions highlights the significance of intergenic DNA sequences and may contribute to the identification of new therapeutic targets for the treatment of pre-B ALL.
引用
收藏
页码:2156 / 2164
页数:9
相关论文